Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results